Trial NCT00215943

View at ClinicalTrials.gov 
Org. Study IDs: MCC-13043
Secondary IDs: CZOL446E

Last trial update was posted on 2014-04-17

MeSH Interventions

Dexamethasone Doxorubicin Liposomal doxorubicin Thalidomide Vincristine Zoledronic Acid

MeSH Conditions

Multiple Myeloma

Other Conditions


Stopping Reasons

Poor accrual, changes in management of newly diagnosed myeloma patients, new drugs/more effective regimens.

Limitations And Caveats

Target accrual for planned analysis (176) was not met. Principal Investigator (PI) determined study must close due to changes in the management of newly diagnosed myeloma (emergence of new drugs, more effective regimens).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID